Marrone Bio Innovations Inc (MBII)
US57165B1061 - Common Stock
| TTM (2022-3-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -20.89M | -16.55M | -20.17M | -37.18M | -20.21M | |||
| Depreciation Amortization | 3.55M | 3.53M | 3.56M | 2.35M | 1.89M | |||
| Change In Working Capital | 40.00K | -830.00K | -5.88M | 770.00K | -2.14M | |||
| Interest Paid | 1.53M | 1.38M | 1.17M | 1.18M | 2.77M | |||
| Taxes Paid | N/A | 90.00K | N/A | N/A | N/A | |||
| Other non cash items | 3.97M | 3.89M | 6.53M | 12.72M | 1.03M | |||
| OPERATING CASH FLOW | -13.34M | -9.96M | -15.96M | -21.34M | -19.43M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.17M | -1.09M | -560.00K | -970.00K | -580.00K | |||
| Other Investing Activity | N/A | -750.00K | -1.24M | -5.83M | 0.00 | |||
| INVESTING CASH FLOW | -1.17M | -1.84M | -1.80M | -6.79M | -580.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 1.08M | 5.49M | 5.02M | -20.00K | 2.54M | |||
| Stock Issued/Repurchased | N/A | 9.81M | 22.18M | 16.06M | 34.61M | |||
| Other Financing Activity | 270.00K | 290.00K | 150.00K | 130.00K | -200.00K | |||
| FINANCING CASH FLOW | 4.95M | 15.59M | 27.35M | 16.16M | 36.95M | |||
| CHANGE IN CASH | -9.56M | 3.79M | 9.59M | -11.97M | 16.94M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -13.34M | -9.96M | -15.96M | -21.34M | -19.43M | |||
| Capital Expenditure | -1.17M | -1.09M | -560.00K | -970.00K | -580.00K | |||
| FREE CASH FLOW | -14.51M | -11.05M | -16.52M | -22.31M | -20.01M | |||
All data in USD